John P. Sharp - 03 Nov 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
Chief Financial Officer
Signature
/s/ John P. Sharp
Issuer symbol
N/A
Transactions as of
03 Nov 2021
Net transactions value
$0
Form type
4
Filing time
03 Nov 2021, 19:30:34 UTC
Previous filing
03 Sep 2021
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise $12,600 +7,500 +15% $1.68* 57,724 03 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Employee Stock Option (right to buy) Options Exercise $12,600 -7,500 -7.6% $1.68* 90,582 03 Nov 2021 Common Stock 7,500 $1.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.